Position in CELC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$48,291,650
-$3,878,319 QoQ
Shares Held
461,591
+1.0% QoQ
Ownership
0.943%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#29
of 273 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Artisan Partners Limited Partnership holds $3,449,495,070 across 23 Biotechnology names. CELC ranks #6 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
1,508,778 | $1,399,798,965 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,634,024 | $702,546,881 | |
| 3 | INSM |
INSMED Inc
|
5,441,718 | $580,195,973 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
2,640,024 | $209,327,502 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
210,205 | $112,869,574 | |
| 6 | CELC |
Celcuity Inc.
This page
|
461,591 | $48,291,650 | |
| 7 | LEGN |
Legend Biotech Corp
|
1,559,441 | $45,036,656 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
354,816 | $39,395,220 |
All Filings in CELC
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,291,650 | 461,591 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $52,169,969 | 457,070 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $54,521,973 | 546,641 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $28,943,064 | 585,892 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,362,401 | 401,678 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,596,471 | 454,646 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,433,826 | 491,507 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,197,744 | 415,677 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,091,196 | 432,918 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||